Skip to content
Lower risk Drug recall · FDA · Published April 30, 2019

Sagent Ketorolac Injection Recall: Microbial Growth Risk

Sagent Pharmaceuticals recalls Ketorolac injection vials due to potential microbial growth during manufacturing. This could introduce harmful bacteria into the product. Affected vials have specific NDC and lot numbers.

🇺🇸 FDA recall #D-1274-2019DrugSagent Pharmaceuticals ›
Take action

Contact the company

Recalling firmSagent Pharmaceuticals Inc1901 N Roselle Rd Ste 700 · Schaumburg, IL 60195-3194
✎ GovInfoNow plain-language explainer

Sagent Pharmaceuticals is recalling Ketorolac injection vials because testing found possible microbial contamination during production. This could lead to infections if the medication is used. Read more at govinfonow.com/recall/38867-sagent-ketorolac-injection-recall-microbial-growth-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38867-sagent-ketorolac-injection-recall-microbial-growth-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1274-2019

Cite this page

“Sagent Ketorolac Injection Recall: Microbial Growth Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38867-sagent-ketorolac-injection-recall-microbial-growth-risk. Based on FDA recall #D-1274-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1274-2019%22&limit=1).

The FDA announced on April 30, 2019, that Sagent Pharmaceuticals Inc voluntarily recalled Ketorolac Tromethamine Injection due to a lack of sterility assurance. The agency stated the recall was initiated after microbial growth was detected during a manufacturing process simulation.

How to tell if you have it

  • Brand: Sagent Pharmaceuticals
  • Product: Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials
  • NDC: 25021-701-02
  • Lot #: M813513
  • Expiration: Feb 2020
  • Units affected: 75,825 vials

The hazard

The recall addresses the potential introduction of microorganisms into the products due to microbial growth detected during a routine simulation of the manufacturing process. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Sagent Pharmaceuticals Inc has issued 10 other recalls since June 7, 2013. Other recent recalls of similar products include Sagent Busulfan Injection (May 4, 2026), Fresenius Kabi Famotidine Injection (Nov. 6, 2025), and Fresenius Kabi Ketamine HCl Injection (Feb. 5, 2026).

How to tell if you have this one

Check for vials labeled 'Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only'. The NDC number is 25021-701-02 and lot number M813513.

  • Brand
    Sagent Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Details

    Look for the NDC number 25021-701-02 and lot number M813513 on the vial label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Apr 30, 201912. FDA classified it Class II: May 9, 201923. Published in FDA’s Enforcement Report: May 15, 201934. FDA terminated the recall: Sep 28, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates potential microbial contamination, so it is not safe to use without confirmation from the manufacturer.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1274-2019 (April 30, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1274-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA